Intrathecal Analgesic Drug Delivery is Effective for Analgesia in a Patient with Post-Poliomyelitis Syndrome: A Case Report

por van Tilburg, Cornelis W.J.
Publicado 2016

Percutaneous Pulsed Radiofrequency Treatment in a Patient with Chronic Bilateral Painful Glossopharyngeal Neuropathy

por van Tilburg, Cornelis Wilhelmus Jacobus
Publicado 2020

Randomized Sham-controlled Double-Blind Multicenter Clinical Trial to Ascertain the Effect of Percutaneous Radiofrequency Treatment for Sacroiliac Joint Pain: Three-month Results

por van Tilburg, Cornelis W.J., Schuurmans, Fleur A., Stronks, Dirk L., Groeneweg, Johannes G., Huygen, Frank J.P.M.
Publicado 2016

S112: THE EFFECT OF IMMUNOGLOBULIN PROPHYLAXIS ON INFECTIOUS MORBIDITY IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF A RANDOMIZED CONTROLLED TRIAL

por Thus, Kirsten, de Groot-Kruseman, Hester, Winkler-Seinstra, Pauline, Seegers, Heidi, Fiocco, Marta, van Tilburg, Cornelis, Pieters, Rob, Bierings, Marc
Publicado 2023

MODL-01. Targeting replication stress in pediatric brain tumors

por Krausert, Sonja, Mack, Norman, Schwalm, Benjamin, Peterziel, Heike, Oehme, Ina, van Tilburg, Cornelis M, Witt, Olaf, Pfister, Stefan M, Kool, Marcel
Publicado 2022

Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells

por Vollmer, Johanna, Ecker, Jonas, Hielscher, Thomas, Valinciute, Gintvile, Ridinger, Johannes, Jamaladdin, Nora, Peterziel, Heike, van Tilburg, Cornelis M., Oehme, Ina, Witt, Olaf, Milde, Till
Publicado 2023

HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours

por Nysom, Karsten, Doz, François, Geoerger, Birgit, Øra, Ingrid, Perreault, Sebastien, Norenberg, Ricarda, Fellous, Marc, De La Cuesta, Esther, Laetsch, Theodore W, van Tilburg, Cornelis M
Publicado 2022

EPCT-06. PRECISION ONCOLOGY IN THE PEDIATRIC TARGETED THERAPY 2.0 PROGRAM

por Ecker, Jonas, Selt, Florian, Korshunov, Andrey, Capper, David, Dikow, Nicola, Hirsch, Steffen, Sutter, Christian, van Tilburg, Cornelis, von Deimling, Andreas, Jones, David T W, Pfister, Stefan M, Sahm, Felix, Witt, Olaf, Milde, Till
Publicado 2021

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

por Italiano, Antoine, Nanda, Shivani, Briggs, Andrew, Garcia-Foncillas, Jesus, Lassen, Ulrik, Vassal, Gilles, Kummar, Shivaani, van Tilburg, Cornelis M., Hong, David S., Laetsch, Theodore W., Keating, Karen, Reeves, John A., Fellous, Marc, Childs, Barrett H., Drilon, Alexander, Hyman, David M.
Publicado 2020

Response to trametinib treatment in progressive pediatric low-grade glioma patients

por Selt, Florian, van Tilburg, Cornelis M., Bison, Brigitte, Sievers, Philipp, Harting, Inga, Ecker, Jonas, Pajtler, Kristian W., Sahm, Felix, Bahr, Annabelle, Simon, Michèle, Jones, David T. W., Well, Lennart, Mautner, Victor-Felix, Capper, David, Hernáiz Driever, Pablo, Gnekow, Astrid, Pfister, Stefan M., Witt, Olaf, Milde, Till
Publicado 2020

EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

por Goto, Hiroaki, Geoerger, Birgit, DuBois, Steven G, Grilley-Olson, Juneko E, van Tilburg, Cornelis M, Schulte, Johannes, Kang, Hyoung Jin, Tahara, Makoto, Boni, Valentina, Perreault, Sebastien, Capra, Michael, Reeves, John A, Brega, Nicoletta, Childs, Barrett H, Laetsch, Theodore W, Ziegler, David S, Doz, François
Publicado 2020

LGG-17. SYNERGISTIC ACTIVITY OF MAPK INHIBITOR CLASSES REVEALED BY A NOVEL CELL-BASED MAPK ACTIVITY PEDIATRIC LOW-GRADE GLIOMA ASSAY

por Usta, Diren, Sigaud, Romain, Buhl, Juliane L, Selt, Florian, Marquardt, Viktoria, Pauck, David, Pusch, Stefan, Ecker, Jonas, Hielscher, Thomas, Vollmer, Johanna, Sommerkamp, Alexander C, Rubner, Tobias, Hargrave, Darren, van Tilburg, Cornelis M, Pfister, Stefan M, Jones, David T W, Remke, Marc, Brummer, Tilman, Witt, Olaf, Milde, Till
Publicado 2020

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory hig...

por van Tilburg, Cornelis M., Witt, Ruth, Heiss, Melanie, Pajtler, Kristian W., Plass, Christoph, Poschke, Isabel, Platten, Michael, Harting, Inga, Sedlaczek, Oliver, Freitag, Angelika, Meyrath, David, Taylor, Lenka, Balasubramanian, Gnana Prakash, Jäger, Natalie, Pfaff, Elke, Jones, Barbara C., Milde, Till, Pfister, Stefan M., Jones, David T. W., Kopp-Schneider, Annette, Witt, Olaf
Publicado 2020

LGG-14. LOGGIC (Low Grade Glioma in Children) Core BioClinical Data Bank: Establishment and added clinical value of an international molecular diagnostic registry for pediatric low...

por Hardin, Emily C, Schmid, Simone, Sommerkamp, Alexander, le Simon, Michè, Caspar, Claudia, Bodden, Carina, Heipertz, Anna-Elisa, Sievers, Philipp, Wittmann, Andrea, Perera, Ashwyn A, Milde, Till, Pfister, Stefan M, von Deimling, Andreas, Driever, Pablo Hernáiz, Koch, Arend, Hargrave, Darren, Witt, Olaf, Capper, David, Sahm, Felix, Jones, David T W, van Tilburg, Cornelis M
Publicado 2022

Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells

por Valinciute, Gintvile, Ecker, Jonas, Selt, Florian, Hielscher, Thomas, Sigaud, Romain, Ridinger, Johannes, Thatikonda, Venu, Gatzweiler, Charlotte, Robinson, Sarah, Talbot, Julie, Bernardi, Flavia, Picard, Daniel, Blattner-Johnson, Mirjam, Schmid, Simone, Jones, David T., van Tilburg, Cornelis M., Capper, David, Kool, Marcel, Remke, Marc, Oehme, Ina, Pfister, Stefan M., Roussel, Martine F., Ayrault, Olivier, Witt, Olaf, Milde, Till
Publicado 2023

Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective study

por Saffari, Afshin, Brösse, Ines, Wiemer-Kruel, Adelheid, Wilken, Bernd, Kreuzaler, Paula, Hahn, Andreas, Bernhard, Matthias K., van Tilburg, Cornelis M., Hoffmann, Georg F., Gorenflo, Matthias, Hethey, Sven, Kaiser, Olaf, Kölker, Stefan, Wagner, Robert, Witt, Olaf, Merkenschlager, Andreas, Möckel, Andreas, Roser, Timo, Schlump, Jan-Ulrich, Serfling, Antje, Spiegler, Juliane, Milde, Till, Ziegler, Andreas, Syrbe, Steffen
Publicado 2019

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

por Stenzinger, Albrecht, van Tilburg, Cornelis M., Tabatabai, Ghazaleh, Länger, Florian, Graf, Norbert, Griesinger, Frank, Heukamp, Lukas C., Hummel, Michael, Klingebiel, Thomas, Hettmer, Simone, Vokuhl, Christian, Merkelbach-Bruse, Sabine, Overkamp, Friedrich, Reichardt, Peter, Scheer, Monika, Weichert, Wilko, Westphalen, C. Benedikt, Bokemeyer, Carsten, Ivanyi, Philipp, Loges, Sonja, Schirmacher, Peter, Wörmann, Bernhard, Bielack, Stefan, Seufferlein, Thomas T. W.
Publicado 2020

RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

por Perreault, Sébastien, Doz, François, Geoerger, Birgit, Nysom, Karsten, Øra, Ingrid, Boni, Valentina, Chisholm, Julia, DuBois, Steven G, Gerber, Nicolas U, Goto, Hiroaki, Grilley-Olson, Juneko E, Hansford, Jordan R, Kang, Hyoung Jin, Capra, Michael, Schulte, Johannes H, Stefanowicz, Joanna, Tahara, Makoto, Ziegler, David S, Norenberg, Ricarda, Dima, Laura, De La Cuesta, Esther, Laetsch, Theodore W, van Tilburg, Cornelis M
Publicado 2021

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitor...

por Sigaud, Romain, Rösch, Lisa, Gatzweiler, Charlotte, Benzel, Julia, von Soosten, Laura, Peterziel, Heike, Najafi, Sara, Ayhan, Simay, Gerloff, Xena F, Hofmann, Nina, Büdenbender, Isabel, Foerster, Kathrin I, Burhenne, Jürgen, Longuespée, Rémi, van Tilburg, Cornelis M, Jones, David T W, Pfister, Stefan M, Knoerzer, Deborah, Kreider, Brent, Sauter, Max, Pajtler, Kristian W, Zuckermann, Marc, Oehme, Ina, Witt, Olaf, Milde, Till
Publicado 2022

LGG-26. Predicting MAPK inhibitor sensitivity in pediatric low-grade gliomas with novel gene expression-derived signatures

por Sigaud, Romain, Heß, Caroline, Hielscher, Thomas, Winkler, Nadine, Selt, Florian, Kocher, Daniela, Nonnenbroich, Leo, Usta, Diren, Sommerkamp, Alex, Büdenbender, Isabel, Capper, David, Thomale, Ulrich W, Driever, Pablo Hernáiz, le Simon, Michè, Koch, Arend, Jabado, Nada, Andrade, Augusto F, van Meeteren, Netteke Schouten-, Hoving, Eelco, van Tilburg, Cornelis M, Pfister, Stefan M, Witt, Olaf, Jones, David T W, Milde, Till
Publicado 2022